Young-hyuck H. Im
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 161 publications
KEYLYNK-009: Pembrolizumab plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer after Clinical Benefit from First-Line Pembrolizumab plus Chemotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 19, 2025
Combined Biomarkers for Prediction of Immune Checkpoint Inhibitor Response in Patients With Triple-negative Breast Cancer.
Journal: Anticancer research
Published: February 12, 2025
Phase Ib/II Study of Zanidatamab in Combination with Tislelizumab and Chemotherapy in First-Line HER2-Positive Gastric/Gastroesophageal Junction Adenocarcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 13, 2025
Spatial and genomic profiling of residual breast cancer after neoadjuvant chemotherapy unveil divergent fates for each breast cancer subtype.
Journal: Cell reports. Medicine
Published: January 03, 2025
Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 11, 2024
Breast cancers with neuroendocrine differentiation: Retrospective case studies series from a single institution based on the 2019 WHO classification.
Journal: Cancer treatment and research communications
Published: July 30, 2024
Neoadjuvant Chemotherapy Response in Triple-Negative Apocrine Carcinoma: Comparing Apocrine Morphology, Androgen Receptor, and Immune Phenotypes.
Journal: Archives of pathology & laboratory medicine
Published: May 24, 2024
Clinical characteristics and management of orbital apex syndrome: a 10-year multicentre experience.
Journal: Rhinology
Published: May 16, 2024
The Survival and Financial Benefit of Investigator-Initiated Trials Conducted by Korean Cancer Study Group.
Journal: Cancer research and treatment
Published: April 30, 2024
Oncological outcomes in patients with residual triple-negative breast cancer after preoperative chemotherapy.
Journal: Radiation oncology journal
Published: January 25, 2024
Prognostic value of structural variants in early breast cancer patients.
Journal: NPJ breast cancer
Published: January 03, 2024
A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Journal: International journal of molecular sciences
Published: September 13, 2023
Last Updated: 09/26/2026